United Therapeutics Corp
XMUN:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
XMUN:UTH
|
US |
|
K
|
Koninklijke Philips NV
DUS:PHI1
|
NL |
|
C
|
Cohort PLC
F:C7K
|
UK |
|
Cohort PLC
LSE:CHRT
|
UK |
|
Equitable Holdings Inc
F:AXJ
|
US |
|
O
|
Occidental Petroleum Corp
XMUN:OPC
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
Angi Inc
F:2UH0
|
US |
|
I
|
Imperial Oil Ltd
F:IMP
|
CA |
|
M
|
MTU Aero Engines AG
XMUN:MTX
|
DE |
|
A
|
ADTRAN Inc
F:ATN
|
US |
|
Virgin Galactic Holdings Inc
F:0QL0
|
US |
|
Himax Technologies Inc
NASDAQ:HIMX
|
TW |
|
U
|
United Therapeutics Corp
XBER:UTH
|
US |
Wall St Price Targets
UTH Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for UTH is 620.43 EUR with a low forecast of 474.54 EUR and a high forecast of 717.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTH's stock price target?
Price Target
620.43
EUR
According to Wall Street analysts, the average 1-year price target for UTH is 620.43 EUR with a low forecast of 474.54 EUR and a high forecast of 717.06 EUR.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.
